Abnormal Levels of Inflammatory and Oxidative Stress Markers in Patients with Arterial Hypertension and Diabetes Mellitus

1. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135-43.10.1161/hc0902.104353Search in Google Scholar

2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003; 169(2): 203-14.10.1016/S0021-9150(03)00012-1Search in Google Scholar

3. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BM J. 2000;321 (7255): 199-204.10.1136/bmj.321.7255.199Search in Google Scholar

4. Castoldi G, Galimbertim S, Riva C, Papagna R, Querci F, Casati M, et al. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci (Lond). 2007; 113(2): 103-8.10.1042/CS20060338Search in Google Scholar

5. Elkind M. Inflammatory mechanisms of stroke. Stroke. 2010; 41 (10 Suppl):S3-S8.10.1161/STROKEAHA.110.594945Search in Google Scholar

6. Libby P, Ridker P. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004; 116(6 Suppl 1):9S-16S.10.1016/j.amjmed.2004.02.006Search in Google Scholar

7. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2): 115-26.10.1056/NEJM199901143400207Search in Google Scholar

8. Di Napoli M, Elkind M, Godoy D, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther. 2011 ;9( 12): 1565-84.10.1586/erc.11.159Search in Google Scholar

9. Pasupathi P, Farook J, Chinnaswamy P. Oxidant-antioxidant status, high sensitive C-reactive protein and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Int J Biol Med Res. 2010; 1 (3) :04-8.Search in Google Scholar

10. Likidlilid A, Patchanans N, Peerapatdit T. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010;93(6):682-93.Search in Google Scholar

11. Lindsberg P, Grau A. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34(10):2518-32.10.1161/01.STR.0000089015.51603.CCSearch in Google Scholar

12. Saito M, Ishimittsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional risk factors. Atherosclerosis. 2003; 167( 1 ):73-9.10.1016/S0021-9150(02)00380-5Search in Google Scholar

13. Anand A, Manikandan R, Begum T, Kumar K, Akilandeswari G, Jerline M, et al. Hypertension, diabetes, metabolic syndrome, inflammation and the risk of stroke. Int J Biol Med Res. 2011 ;2( 1 ):429-32.Search in Google Scholar

14. Savoia C, Schiffrin E. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond). 2007; 112(7):375-84.10.1042/CS2006024717324119Search in Google Scholar

15. Di Napoli M, Papa F. Inflammation, hemostatic factors and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002; 33:1763-71.10.1161/01.STR.0000019124.54361.08Search in Google Scholar

16. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8 Suppl): 1544-51.10.1902/jop.2008.08024918673009Search in Google Scholar

17. Biswas UK, Kumar A. Study on lipid profile, oxidation stress and carbonic anhydrase activity in patients with essential hypertension. J Clin Diag Res. 2010;4:3414-20.Search in Google Scholar

18. Kusano C, Ferrari B. Total antioxidant capacity: a biomarker in biomedical and nutritional studies. J Cell Mol Biol. 2008;7(1): 1-15.Search in Google Scholar

19. Mahboob M, Rahman M, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005;46(7):322-4. Search in Google Scholar